155 related articles for article (PubMed ID: 2391357)
1. Comparative studies on the expression of gastrointestinal-cancer-associated antigen, PA8-15, CA19-9 and the blood-group antigens in non-malignant and malignant human pancreatic tissues.
Egami H; Sakamoto K; Yoshimura R; Arai M; Takiyama Y; Pour PM
J Cancer Res Clin Oncol; 1990; 116(4):365-71. PubMed ID: 2391357
[TBL] [Abstract][Full Text] [Related]
2. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer.
Schuessler MH; Pintado S; Welt S; Real FX; Xu M; Melamed MR; Lloyd KO; Oettgen HF
Int J Cancer; 1991 Jan; 47(2):180-7. PubMed ID: 1988363
[TBL] [Abstract][Full Text] [Related]
3. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
4. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein.
Ichihara T; Sakamoto J; Nakao A; Furukawa K; Watanabe T; Suzuki N; Horisawa M; Nagura H; Lloyd KO; Takagi H
Cancer; 1993 Jan; 71(1):71-81. PubMed ID: 8416729
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific expression of cancer-associated type 1 and type 2 chain polylactosamine antigens in the developing pancreas of human embryos.
Tuo XH; Itai S; Nishikata J; Mori T; Tanaka O; Kannagi R
Cancer Res; 1992 Oct; 52(20):5744-51. PubMed ID: 1394198
[TBL] [Abstract][Full Text] [Related]
6. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumor associated antigen, PA8-15, in sera from pancreatic and gastrointestinal carcinoma patients.
Arai M; Sakamoto K; Otsuka H; Yokoyama Y; Akagi M
Jpn J Clin Oncol; 1990 Jun; 20(2):145-53. PubMed ID: 2370693
[TBL] [Abstract][Full Text] [Related]
8. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
9. Expression of Tn, sialosyl Tn, and T antigens in human pancreas.
Itzkowitz S; Kjeldsen T; Friera A; Hakomori S; Yang US; Kim YS
Gastroenterology; 1991 Jun; 100(6):1691-700. PubMed ID: 1850375
[TBL] [Abstract][Full Text] [Related]
10. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
11. Lex and Ley antigen expression in human pancreatic cancer.
Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
[TBL] [Abstract][Full Text] [Related]
12. Expression of blood group-related carbohydrate antigens in normal human pancreatic tissue.
Philipsen EK; Jørgensen M; Dabelsteen E
APMIS; 1991 Oct; 99(10):931-40. PubMed ID: 1930966
[TBL] [Abstract][Full Text] [Related]
13. Blood-group antigen expression during pancreatic cancer induction in hamsters.
Pour PM; Uchida E; Burnett DA; Steplewski Z
Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427
[TBL] [Abstract][Full Text] [Related]
14. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.
Satomura Y; Sawabu N; Takemori Y; Ohta H; Watanabe H; Okai T; Watanabe K; Matsuno H; Konishi F
Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888
[TBL] [Abstract][Full Text] [Related]
15. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J; Schwenk J
Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
[No Abstract] [Full Text] [Related]
17. Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.
Macdonald F; Downing R; Allum WH
Br J Cancer; 1988 Oct; 58(4):505-6. PubMed ID: 3207606
[No Abstract] [Full Text] [Related]
18. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma.
Lucarotti ME; Habib NA; Kelly SB; Rothnie ND; Nelson O; Lindholm L; Cooper MJ; Wood CB; Williamson RC
Eur J Surg Oncol; 1991 Feb; 17(1):51-3. PubMed ID: 1995358
[TBL] [Abstract][Full Text] [Related]
19. Significance of adenocarcinoma-associated antigen YH206 levels in the pancreatic juice.
Imai K; Ban T; Endo T; Hinoda Y; Sugiyama T; Hirane T; Yabana T; Hirata K; Wada T; Yachi A
Gastroenterol Jpn; 1990 Feb; 25(1):112-6. PubMed ID: 2407594
[TBL] [Abstract][Full Text] [Related]
20. Murine monoclonal antibodies to human pancreatic cancer: specificity and sensitivity.
Jakowatz JG; Gan K; Ulich TR; Wile AG
Oncology; 1990; 47(2):149-54. PubMed ID: 2314827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
